Nonacog gamma, a novel recombinant factor IX with low factor IXa content for treatment and prophylaxis of bleeding episodes-Reference-Cited by-同舟云学术

Nonacog gamma, a novel recombinant factor IX with low factor IXa content for treatment and prophylaxis of bleeding episodes

Published:2015-02-08 Issue:2 Volume:8 Page:163-177
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Turecek Peter L,Abbühl Brigitt,Tangada Srilatha D,Chapman Miranda,Gritsch Herbert,Rottensteiner Hanspeter,Schrenk Gerald,Mitterer Artur,Dietrich Barbara,Höllriegl Werner,Schiviz Alexandra,Horling Frank,Reipert Birgit M,Muchitsch Eva-Maria,Pavlova Borislava G,Scheiflinger Friedrich

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1586/17512433.2015.1011126

Reference39 articles.

1. Haemophilia B: database of point mutations and short additions and deletions--eighth edition

2. Insight into molecular changes of the FIX protein in a series of Italian patients with haemophilia B

3. Structural analysis of factor IX protein variants to predict functional aberration causing haemophilia B

4. BAX326 (recombinant coagulation factor IX) for the treatment and prophylaxis of hemophilia B

5. Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Post-Authorization Safety Surveillance Study to Report Clinical Experience with Purified Factor IX Concentrate in Pediatric Patients with Hemophilia B;Journal of Blood Medicine;2024-03

2. Factor VIII and IX assays for post‐infusion monitoring in hemophilia patients: Guidelines from the French BIMHO group (GFHT);European Journal of Haematology;2020-05-27

3. Identification of novel glycosylation events on human serum-derived factor IX;Glycoconjugate Journal;2020-05-06

4. Real‐world assay variability between laboratories in monitoring of recombinant factor IX Fc fusion protein activity in plasma samples;International Journal of Laboratory Hematology;2020-03-23

5. Factor IX assays in treated hemophilia B patients;HEMATOLOGIE;2020